XM does not provide services to residents of the United States of America.

Eni in talks with funds on another Plenitude stake sale, sources say



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>EXCLUSIVE-Eni in talks with funds on another Plenitude stake sale, sources say</title></head><body>

By Francesca Landini

MILAN, Sept 13 (Reuters) -Italian energy group Eni ENI.MI is in talks with several funds over the potential sale of a minority stake in its renewable and retail business Plenitude, two sources with knowledge of the matter said on Friday.

The possible sale would be another step in Eni's strategy of tapping specialised investors to help fund the group's energy transition. In March, Eni completed the sale of 7.6% in Plenitude to Energy Infrastructure Partners.

The sources told Reuters talks between Eni and investors interested in the low-carbon business were based on a valuation for Plenitude of more than 10 billion euros ($11.08 billion), which is the value at which EIP entered the share capital of the unit earlier this year.

One of the sources said that U.S. asset management firm Apollo Capital Management, Norway's private equity fund HitecVision and London-based private equity firm Trilantic Europe were among the investors interested in the potential acquisition of a stake of around 10% in Plenitude.

Eni declined to comment.

Apollo, HitecVision and Trilantic were not immediately available for comment.

Plenitude generates power from renewables, sells electricity, gas and energy services to households and businesses, and is developing a network of charging points for electric vehicles. It targets earnings before interest, taxes, depreciation and amortisation of 1 billion euros this year, up from 0.9 billion euros in 2023.

Under its so-called satellite strategy, Eni is creating separate units focusing on specific businesses, such as renewable energy and biofuels, and is clinching partnerships with investors interested in supporting their growth.

In July, the state-controlled group announced exclusive talks with U.S. investment company KKR over the sale of up to 25% of its biofuel business Enilive.


($1 = 0.9023 euros)



Reporting by Francesca Landini. Editing by Jane Merriman

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.